title: Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma.
abstract: BACKGROUND
  MYST1 (also known as hMOF), a member of the MYST family of histone acetyltransferases (HATs) as an epigenetic mark of active genes, is mainly responsible for histone H4K16 acetylation in the cells. Recent studies have shown that the abnormal gene expression of hMOF is involved in certain primary cancers. Here we examined the involvement of hMOF expression and histone H4K16 acetylation in primary renal cell carcinoma (RCC). Simultaneously, we investigated the correlation between the expression of hMOF and clear cell RCC (ccRCC) biomarker carbohydrase IX (CA9) in RCC.
  
  
  METHODS
  The frozen RCC tissues and RCC cell lines as materials, the reverse transcription polymerase chain reaction (RT-PCR), western blotting and immunohistochemical staining approaches were used.
  
  
  RESULTS
  RT-PCR results indicate that hMOF gene expression levels frequently downregulated in 90.5% of patients (19/21) with RCC. The reduction of hMOF protein in both RCC tissues and RCC cell lines is tightly correlated with acetylation of histone H4K16. In addition, overexpression of CA9 was detected in 100% of ccRCC patients (21/21). However, transient transfection of hMOF in ccRCC 786-0 cells did not affect both the gene and protein expression of CA9.
  
  
  CONCLUSIONS
  hMOF as an acetyltransferase of H4K16 might be involved in the pathogenesis of kidney cancer, and this epigenetic changes might be a new CA9-independent RCC diagnostic maker.
authors: Urology Department, The First Clinical Hospital, Jilin University, Changchun City, Jilin 130021, China.
authors: Yong
authors: Y
authors: Wang
authors: Rui
authors: R
authors: Zhang
authors: Donglu
authors: D
authors: Wu
authors: Zhihua
authors: Z
authors: Lu
authors: Wentao
authors: W
authors: Sun
authors: Yong
authors: Y
authors: Cai
authors: Chunxi
authors: C
authors: Wang
authors: Jingji
authors: J
authors: Jin
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D015153:Blotting, Western; D002292:Carcinoma, Renal Cell / Q000201:enzymology* / Q000235:genetics; D015536:Down-Regulation; D044127:Epigenesis, Genetic; D057890:Epigenomics; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D057809:HEK293 Cells; D051548:Histone Acetyltransferases / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D007680:Kidney Neoplasms / Q000201:enzymology* / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014162:Transfection
chemical_list: D014408:Biomarkers, Tumor; D051548:Histone Acetyltransferases; C496552:KAT8 protein, human
references: Oncogene. 2007 Aug 13;26(37):5385-94
references: 17694080
references: Int J Cancer. 2008 Mar 15;122(6):1207-13
references: 18058815
references: J Biol Chem. 2010 Feb 12;285(7):4268-72
references: 20018852
references: Urol Clin North Am. 2003 Nov;30(4):843-52
references: 14680319
references: Cancer Sci. 2010 Dec;101(12):2664-9
references: 20825416
references: Br J Cancer. 2007 Jan 15;96(1):104-9
references: 17213826
references: Eur Urol. 2009 Apr;55(4):851-63
references: 19155123
references: Nat Struct Mol Biol. 2007 Nov;14(11):1008-16
references: 17984963
references: Virchows Arch. 2011 Aug;459(2):193-200
references: 21691815
references: Eur J Surg Oncol. 2013 Jan;39(1):100-6
references: 23102595
references: Trends Genet. 2003 Jun;19(6):321-9
references: 12801725
references: Mol Cell. 2006 Mar 17;21(6):811-23
references: 16543150
references: Mol Cell Biol. 2005 Aug;25(15):6798-810
references: 16024812
references: Mol Cell. 2006 Dec 28;24(6):841-51
references: 17189187
references: J Clin Oncol. 2007 Oct 20;25(30):4757-64
references: 17947723
references: J Clin Oncol. 2003 Feb 1;21(3):473-82
references: 12560438
references: Cancer Res. 2009 May 1;69(9):3802-9
references: 19366799
references: EMBO J. 2010 Jul 21;29(14):2381-94
references: 20562830
references: Cancer Res. 1997 Jul 15;57(14):2827-31
references: 9230182
references: Mol Cell. 2011 Jun 10;42(5):689-99
references: 21596603
references: Mol Cell Biol. 2005 Nov;25(21):9175-88
references: 16227571
references: Cancer. 2009 Apr 1;115(7):1448-58
references: 19195047
references: Trends Biochem Sci. 2005 Dec;30(12):680-7
references: 16257529
references: Nature. 2007 May 24;447(7143):407-12
references: 17522673
references: Eur Urol. 2010 Jul;58(1):75-83
references: 20359812
references: Mol Cell Biol. 2010 Jul;30(14):3582-95
references: 20479123
references: CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
references: 17237035
references: Eur J Cancer. 2010 Dec;46(18):3141-8
references: 20709527
references: Mol Cell Biol. 2008 Jan;28(1):397-409
references: 17967868